Scarica l'app Stockscreener
6.615
4.50%
0.285
Taysha Gene Therapies Inc Borsa (TSHA) Ultime notizie
Taysha Gene Therapies (TSHA) to Release Earnings on Wednesday - MarketBeat
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Five new Taysha hires get 188,000 stock units under Nasdaq rule - Stock Titan
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 - Investing News Network
Biotech Taysha pairs its Q1 results with a corporate update on May 6 - Stock Titan
Earnings update from Taysha Gene Therapies expected next week - Traders Union
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call ... - Caledonian Record
Has Taysha Gene Therapies (TSHA) Run Too Far After A 259% One Year Surge? - Yahoo Finance
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting - Investing News Network
Taysha to present preclinical data on Rett syndrome gene therapy By Investing.com - Investing.com Canada
Taysha Gene Therapies Reports Preclinical Data Supporting TSHA-102 Gene Therapy for Rett Syndrome at ASGCT Annual Meeting - Quiver Quantitative
Taysha Gene Therapies to Present New Preclinical Data - GlobeNewswire
Taysha Gene Therapies upgraded at Goldman Sachs on advancing Rett syndrome asset - MSN
Taysha Gene Therapies Shares Surge After FDA Grants Breakthrough Therapy Status - MSN
Taysha Gene Therapies stock hits 52-week high at 6.7 USD - Investing.com India
Taysha Gene Therapies, Inc. ($TSHA) CEO and Director 2025 Pay Revealed - Quiver Quantitative
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month HighShould You Buy? - MarketBeat
Taysha Gene Therapies stock hits 52-week high at 6.7 USD By Investing.com - Investing.com South Africa
Taysha Gene Therapies (TSHA) Stock Price Surges 343.45% From Year Ago Levels - Insider Monkey
Executive pay, board seats and auditor up for TSHA (NASDAQ: TSHA) vote - Stock Titan
This is why Taysha Gene Therapies, Inc. (TSHA) is one of the best healthcare penny stocks to buy - MSN
Taysha Gene Therapies (TSHA) making progress on crucial Rett syndrome treatment - MSN
TSHA Stock Jumps As Canaccord Hikes Price Target - StocksToTrade
Taysha Gene Therapies (TSHA) Price Target Raised by JMP on Positive Rett Syndrome Trial Data - MSN
TSHA Jumps As Taysha Gene Therapies Wins Target Hike - StocksToTrade
TSHA Jumps As Taysha Wins Target Hike On Trial Progress - timothysykes.com
Taysha Gene Therapies, Inc. (TSHA) Investor Outlook: Exploring a Potential 94% Upside in the Biotech Arena - DirectorsTalk Interviews
Taysha (TSHA) Stock Treasury Trade (Near Lows) 2026-04-16Breakout Signals - Cổng thông tin điện tử Tỉnh Sơn La
Taysha Gene Therapies Sees Unusually High Options Volume (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies stock hits 52-week high at 6.02 USD - Investing.com Australia
Unusually active option classes on open April 16th - TipRanks
Taysha Gene Therapies (NASDAQ:TSHA) Sets New 12-Month HighStill a Buy? - MarketBeat
Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 9%Should You Buy? - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Brokerages - MarketBeat
This is Why Taysha Gene Therapies, Inc. (TSHA) is one of the Best Healthcare Penny Stocks to Buy - Insider Monkey
5 Best Healthcare Penny Stocks to Buy According to Hedge Funds - Insider Monkey
1.17%
3.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):